(Alliance News) - TheraCryf PLC on Tuesday reported it was in a good position despite "difficult markets" after narrowing its full-year loss. Read More
(Alliance News) - TheraCryf PLC on Monday said it has signed a master service agreement with Pharmaron UK Ltd to progress development of its Orexin-1 addiction programme. Read More
(Alliance News) - TheraCryf PLC said on Thusday its half-year pretax loss narrowed as it advanced drug development programmes in oncology and neuropsychiatry while integrating assets from a recent acquisition. Read More
(Alliance News) - TheraCryf PLC on Wednesday confirmed it had been awarded a Composition of Matter patent in Europe for a new drug treating mental health conditions. Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
